SNSeema Nayak

Seema Nayak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seema Nayak has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Madhu Mati Goel

    Medanta Holding Pvt. Ltd., Lucknow, Uttar Pradesh, India

    3 shared publications
  • Abbas Ali Mahdi

    Department of Biochemistry, King George’s Medical University, Lucknow, Uttar Pradesh, India

    2 shared publications
  • Anupam Mishra

    Department of Otorhinolaryngology, King George’s Medical University, Lucknow, Uttar Pradesh, India

    2 shared publications
  • Divya Mehrotra

    Department of Oral and Maxillofacial Surgery, King George’s Medical University, Lucknow, Uttar Pradesh, India

    2 shared publications
  • Seema Gupta

    Department of Radiotherapy, King George’s Medical University, Lucknow, Uttar Pradesh, India

    2 shared publications
  • Divya Mehrotra

    Department of Oral and Maxillofacial Surgery, King George Medical University, Lucknow, India

    1 shared publication

Latest Publications

  • Open Access

    Aberrant Expression of PTPN-14 and Wilms’ Tumor 1 as Putative Biomarker for Locoregional Recurrence in Oral Squamous Cell Carcinoma

    by Seema Nayak, Madan Lal Brahma Bhatt, Madhu Mati Goel, Seema Gupta, Divya Mehrotra, Abbas Ali Mahdi, Anupam Mishra

    Objective Locoregional recurrence in oral squamous cell carcinoma (OSCC) is a major concern that leads to metastasis. Its detection at earliest stage is very important to increase the overall survival of the patient. There is no any biomarker for locoregional recurrence in oral squamous cell carcinoma (OSCC). The aim of this study was to find a biomarker for locoregional recurrence in tissue and serum at gene and protein level. Methods This work studied the expression of protein tyrosine phosphatase nonreceptor type 14 (PTPN-14) and Wilms’ tumor 1 (WT-1) in patients and correlated their expression with locoregional recurrence and survival. Tissue expression was observed in formalin fixed tissue biopsies of 96 OSCC and 32 healthy controls by immunohistochemistry using antibody against PTPN-14 and WT-1 and serum level was estimated by enzyme-linked immunosorbent assay in pre- and post-chemoradiotherapy samples. mRNA expression was determined by using real-time polymerase chain reaction. Patients were followed for 3 years for locoregional recurrence. Results Expression of PTPN-14 and WT-1 in OSCC was upregulated (aberrant) in tissue and sera in both gene and protein level as compared with healthy controls. Locoregional recurrence was observed in 10 (23.80%) patients and significantly associated with PTPN-14 (p < 0.047) and WT-1 expression (p < 0.031). Conclusion PTPN-14 and WT-1 may be used as biomarker to identify patients for higher risk of locoregional recurrence. This study drove molecular aspect and phenotypic level to derive new emergent strategies in future for recurrent OSCC.


  • Open Access

    IoT in agriculture

    by Seema Nayak, Manoj Nayak, Govind Singh Patel

    The internet of things (IoT) has plentiful applications in different fields. The initiative of IoT has shown a novel track of advanced research in agricultural dominion which is capable of offering many solutions toward the modernization of agriculture. Data are captured by mobile devices and sensors; for broadcasting data radio frequency (RF) technologies are used. To be persistent and functional in an effective way, sensor networks use verification and optimization methods. The processes and predictive analytics can be automated using big data approaches and increase many activities in the real time. This chapter covers the IoT technologies used for developing systems that support different agricultural processes, its applications for agriculture, challenges that IoT faces and future scope for upgradations of IoT in agriculture segment.


  • Open Access

    Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy

    by Seema Nayak, M L B Bhatt, Madhu Mati Goel, Seema Gupta, Abbas Ali Mahdi, Anupam Mishra, Divya Mehrotra

    Radioresistance is one of the main determinants of treatment outcome in oral squamous cell carcinoma (OSCC), but its prediction is difficult. Several authors aimed to establish radioresistant OSCC cell lines to identify genes with altered expression in response to radioresistance. The development of OSCC is a multistep carcinogenic process that includes activation of several oncogenes and inactivation of tumour suppressor genes. TGM-3 is a tumour suppressor gene and contributes to carcinogenesis process. The aim of this study was to estimate serum and tissue expression of TGM-3 and its correlation with clinico-pathological factors and overall survival in patients of OSCC undergoing chemo-radiotherapy. Tissue expression was observed in formalin fixed tissue biopsies of 96 cases of OSCC and 32 healthy controls were subjected to immunohistochemistry (IHC) by using antibody against TGM-3 and serum level was estimated by ELISA method. mRNA expression was determined by using Real-Time PCR. Patients were followed for 2 year for chemo radiotherapy response. In OSCC, 76.70% cases and in controls 90.62% were positive for TGM-3 IHC expression. TGM-3 expression was cytoplasmic and nuclear staining expressed in keratinized layer, stratum granulosum and stratum spinosum in controls and tumour cells. Mean serum TGM-3 in pre chemo-radiotherapy OSCC cases were 1304.83±573.55, post chemo-radiotherapy samples were 1530.64±669.33 and controls were 1869.16±1377.36, but difference was significant in pre chemo-radiotherapy samples as compared to controls (p<0.018). This finding was also confirmed by real- time PCR analysis in which down regulation (-7.92 fold change) of TGM-3 in OSCC as compared to controls. TGM-3 expression was significantly associated with response to chemo-radiotherapy treatment (p<0.007) and overall survival (p<0.015). Patents having higher level of TGM-3 expression have good response to chemo-radiotherapy and also have better overall survival. TGM-3 may serve as a candidate biomarker for responsiveness to chemo-radiotherapy treatment in OSCC patients.


  • Effect of tobacco, alcohol, and smoking habits in oral precancer with histological proven epithelial dysplasia

    by Seema Nayak, Saumya Chandra, Divya Mehrotra, Sumit Kumar, S.P. Agrawal, Sandeep Kumar, Madhu Mati Goel